Correlation Between Fidelity Capital and Evaluator Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity Capital and Evaluator Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Capital and Evaluator Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity Capital Income and Evaluator Growth Rms, you can compare the effects of market volatilities on Fidelity Capital and Evaluator Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Capital with a short position of Evaluator Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Capital and Evaluator Growth.

Diversification Opportunities for Fidelity Capital and Evaluator Growth

0.94
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Fidelity and Evaluator is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Capital Income and Evaluator Growth Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Growth Rms and Fidelity Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Capital Income are associated (or correlated) with Evaluator Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Growth Rms has no effect on the direction of Fidelity Capital i.e., Fidelity Capital and Evaluator Growth go up and down completely randomly.

Pair Corralation between Fidelity Capital and Evaluator Growth

Assuming the 90 days horizon Fidelity Capital is expected to generate 1.5 times less return on investment than Evaluator Growth. But when comparing it to its historical volatility, Fidelity Capital Income is 1.7 times less risky than Evaluator Growth. It trades about 0.2 of its potential returns per unit of risk. Evaluator Growth Rms is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,279  in Evaluator Growth Rms on August 6, 2025 and sell it today you would earn a total of  79.00  from holding Evaluator Growth Rms or generate 6.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Fidelity Capital Income  vs.  Evaluator Growth Rms

 Performance 
       Timeline  
Fidelity Capital Income 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Capital Income are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Fidelity Capital is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Evaluator Growth Rms 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Growth Rms are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Evaluator Growth is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fidelity Capital and Evaluator Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity Capital and Evaluator Growth

The main advantage of trading using opposite Fidelity Capital and Evaluator Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Capital position performs unexpectedly, Evaluator Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Growth will offset losses from the drop in Evaluator Growth's long position.
The idea behind Fidelity Capital Income and Evaluator Growth Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance